MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,765.36
-0.47%
NASDAQ 100
$30,725.81
-1.39%
DOW JONES
$51,232.00
+0.10%
NASDAQ Composite
$27,193.34
-1.25%
RUSSELL 2000
$2,775.70
-0.05%
CBOE VIX
$15.41
+2.19%
Sector Heatmap
Technology-1.79%
Financials+0.89%
Healthcare-0.39%
Consumer Cycl+0.31%
Consumer Staples+2.11%
Energy+2.97%
Industrials+0.33%
Materials+0.59%
Real Estate+0.69%
Utilities-0.19%
Comm Services+0.73%
SERA — Sera Prognostics, Inc. Class A Common Stock
NasdaqSera Prognostics, Inc. Class A Common Stock
$2.02
-0.05(-2.42%)
- O
- 2.21
- H
- 2.21
- L
- 2.01
- V
- 13.38K
⏱️ End-of-day dataAs of Oct 8, 2026
Chart
About SERA
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
IndustrySERVICES-MEDICAL LABORATORIES
SectorNot available
IPO DateJul 15, 2021
Employees72
Stock ExchangeNasdaq
Ticker SymbolSERA
Key Financial Statistics
| Market Cap | $82.45M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $1.56 - $3.95 |
| 52-Week Avg Volume | 46.8K |
| VWAP | $2.03 |
| Transactions | 73 |
| Total Recorded Bars | 1,316 days |